Brown PM, Rogne T, Solligård E. The promise and pitfalls of composite endpoints in sepsis and COVID-19 clinical trials.
Pharm Stat 2020;
20:413-417. [PMID:
32893957 DOI:
10.1002/pst.2070]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2020] [Revised: 08/18/2020] [Accepted: 08/25/2020] [Indexed: 01/19/2023]
Abstract
Composite endpoints reveal the tendency for statistical convention to arise locally within subfields. Composites are familiar in cardiovascular trials, yet almost unknown in sepsis. However, the VITAMINS trial in patients with septic shock adopted a composite of mortality and vasopressor-free days, and an ordinal scale describing patient status rapidly became standard in COVID studies. Aware that recent use could incite interest in such endpoints, we are motivated to flag their potential value and pitfalls for sepsis research and COVID studies.
Collapse